Evidence map›Paper›PMID 34150972›Full record

ArticleGynecologic oncology reports2021

Tracing ovarian cancer research in Morocco: A bibliometric analysis.

Khalid El Bairi, Ouissam Al Jarroudi, Said Afqir

Abstract read
In one paragraph

Article in Gynecologic oncology reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. The OVANORDEST project: making an impact on ovarian cancer in Morocco.International journal of gynecological cancer : official journal of the International Gynecological Cancer Society · 2023
    Article
  3. Article
  4. Article
  5. Ovarian cancer in Morocco: Time to act is now.Gynecologic oncology reports · 2021
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Khalid El BairiDepartment of Medical Oncology, Mohammed VI University Hospital, Oujda, Morocco.
Ouissam Al JarroudiDepartment of Medical Oncology, Mohammed VI University Hospital, Oujda, Morocco.
Said AfqirDepartment of Medical Oncology, Mohammed VI University Hospital, Oujda, Morocco.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe burden of ovarian cancer (OC) in low-income countries continues to increase annually. This gynecological cancer, known for its poor survival outcomes, has not attracted much interest in medical research as compared to other women's malignancies such as breast cancer. This bibliometric study was conducted to better depict the global map and the future directions of scientific productivity in the area of OC research in Morocco.

methodsPublication trends on OC were retrospectively analyzed using a number of bibliometric parameters based on the Pubmed database and other resources.

resultsDuring the time period (1900-2018), a total number of 74 publications responding to the inclusion criteria were found and incorporated in the bibliometric analysis. This was dominated by case reports and case series on rare ovarian tumors (n = 60). In the core cluster, only 10 original studies and 3 reviews on OC were published by Moroccan researchers. After full-text appraisal for study population, only two clinical original articles included OC patients. The other clinical studies included breast cancer patients only or were suggestive of inherited OC. In addition, 3 preclinical

conclusionsThis research area in gynecologic oncology seems to be neglected and needs to be prioritized in future research projects in Morocco particularly given the aggressive behavior of this women's cancer and the few available therapeutic options. There is an unmet need for studies on OC in all fields particularly epidemiology, clinic-pathological characteristics, and survival outcomes.

Indexed as

BibliometricBRCA, Breast cancer susceptibility geneCancer researchGDP, gross domestic productIARC, International Agency for Research on CancerMoroccoOCAC, The Ovarian Cancer Association ConsortiumOC, ovarian cancerOvarian cancerScientometricUS, United StatesWoS, Web of Science

Identifiers

PMID34150972
PMCPMC8192560

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.